Stephen J Mccormack

age ~60

from Claremont, CA

Get Report

Also known as:

Stephen Joseph Mccormack
Stephen A Mccormack
Stephen Joseph Mc
Stephen Joseph Mccormach
Patricia S Mccormack
Patricia M Mccormack
Stephen J Mccorm
Stephen J Mccormick
Stephen Mc Grmack
Stephen Mcgrmack

Phone and address:: 746 Gettysburg Cir, Claremont, CA 91711
9096216224

Connected to:

Stephen Mccormack Phones & Addresses

746 Gettysburg Cir, Claremont, CA 91711 • 9096216224
902 Brigham Young Dr, Claremont, CA 91711 • 7027767795
Las Vegas, NV
Alexandria, VA
Reston, VA
Goleta, CA
Madison, WI
San Diego, CA
Manitowoc, WI
Ashwaubenon, WI
746 Gettysburg Cir, Claremont, CA 91711

Work

Company:

Gwu - cloyd heck marvin center - Washington, DC
Sep 2011
Position:

Student manager

Education

School / High School:

The George Washington University- Washington, DC
May 2012
Specialities:

Bachelor of Science in Mechanical Engineering

Skills

Intermediate proficiency in AutoCAD and ... • Very proficient with Microsoft Excel • Word and other word processing applicati... • Very mechanically inclined and competent... • Strong communication and organizational ...

Resumes

General Partner

view source

Location:

902 Brigham Young Dr, Claremont, CA 91711

Industry:

Biotechnology

Work:

Titan Grove Holdings Aug 2013 - Oct 2017
Operating Partner
Treatment Research Institute Jan 2013 - Jun 2017
Member Board of Directors
Private Investment Office Jan 2013 - Jun 2017
General Partner - Single Family Office - Healthcare
Betty Ford Center Nov 2011 - Mar 2016
Member Board of Trustees - Philanthropy Council
Albany College of Pharmacy and Health Sciences Nov 2011 - Mar 2016
President's Advisory Council

Education:

Harvard Business School 2003 - 2003
Georgetown University Medical Center 1994 - 1997
Georgetown University 1994 - 1997
Uc Santa Barbara 1988 - 1994
Doctorates, Doctor of Philosophy, Molecular Biology, Biochemistry, Biomedical Engineering, Bioengineering College of the Holy Cross 1984 - 1987
Bachelors, Bachelor of Arts, Biology

Skills:

Start Ups
Biotechnology
Medical Devices
Venture Capital
Strategy
Entrepreneurship
Business Development
Lifesciences
Mergers and Acquisitions
Healthcare
Commercialization
Management
Strategic Planning
Due Diligence
Angel Investing
Product Development
Business Strategy
Pharmaceutical Industry
Strategic Partnerships
Private Equity
Biopharmaceuticals
Mergers
Corporate Development
Project Management
Clinical Development
Technology Transfer
Cross Functional Team Leadership
Medicine
Genomics
Drug Development
Hardware Diagnostics
Oncology
Diabetes
Investments
Finance
Medical Services
Competitive Analysis
Counseling Psychology
Healthcare Management
Mental Health
Substance Use Disorders
Addiction Psychiatry
Patent Prosecution
Mental Health Counseling
Health Insurance
Public Sector Financial Management
Patent Litigation
Substance Abuse Prevention
Mental Health Law
Managerial Finance

Interests:

Kids
New Medical Services and Technology
Cooking
Medicine
Electronics
Exercise
Home Improvement
Donor
Crafts
Fitness
Gourmet Cooking
Reading
Food
Home Decoration
Health

Languages:

English
German

Stephen Mccormack

view source

Stephen Mccormack

view source

Business Development Manager At Standard Bank

view source

Position:

Business Development Manager - International Fiduciary Services at Standard Bank

Location:

Jersey

Industry:

Banking

Work:

Standard Bank since Jun 2009
Business Development Manager - International Fiduciary Services
Standard Bank Jun 2008 - Jun 2009
Assistant Manager
JPMorgan Chase Jan 2003 - Jun 2008
Fiduciary Officer
JPMorganChase Aug 1999 - Jan 2003
Senior Custody Administrator
Citibank 1998 - 1999
Settlements

Education:

Waterford Institute of Technology 1996 - 1998
Sancta Maria College 1990 - 1995
Manchester Business School 2011
Bachelor of Science (B.Sc.), Management with Trusts & Estates

Honor & Awards:

Society of Trust and Estate Practitioners Diploma in International Trust Management

Certifications:

Diploma in International Trust Management, Society of Trust and Estate Practitioners (STEP) - http://www.step.org/

Biology Teacher At Svusd

view source

Location:

Orange County, California Area

Industry:

Primary/Secondary Education

Stephen Mccormack

view source

Location:

United States

Stephen Mccormack

view source

Stephen Mccormack

view source

Name / Title

Company / Classification

Phones & Addresses

Stephen J. Mccormack
Director, President, Treasurer

Visus Technology, Inc

8221 Omni Ct, Las Vegas, NV 89149
241 A St, Boston, MA 02210

Stephen Mccormack
Mbr

Exela Hearing Services, LLC
Ret Misc Merchandise

746 Gettysburg Cir, Claremont, CA 91711
9096216224

Stephen Mccormack

EXELA HEARING SERVICES LLC
Hearing Care · Health/Allied Services · Services-Misc

8076 W Sahara Ave, Las Vegas, NV 89117

Stephen Mccormack
M

Mackeyser Holdings LLC
Holding Company

8076 W Sahara Ave, Las Vegas, NV 89117
7029392870

Stephen Mccormack

Exela, LLC
Medical Doctor's Office Ret Misc Foods

746 Gettysburg Cir, Claremont, CA 91711
9096212994, 9096216224

Stephen Mccormack
Director

TELELOGIC I-LOGIX INC

9401 Jeronimo Rd, Irvine, CA 92618

Stephen Mccormack
Chief Executive Officer

Amedco Indiana LLC
Business Services at Non-Commercial Site

8076 W Sahara Ave, Las Vegas, NV 89117

Stephen Mccormack
Chief Executive Officer

Amedco Colorado LLC
Nonclassifiable Establishments

8076 W Sahara Ave, Las Vegas, NV 89117

Us Patents

Modulation Of Allergic Response
view source
US Patent:

6773695, Aug 10, 2004
Filed:

Mar 13, 2001
Appl. No.:

09/804464
Inventors:

Thomas M. KÃ¼ndig - Zurich, CH
Stephen J. McCormack - Claremont CA
Assignee:

MannKind Corporation - Valencia CA
International Classification:

A61K 4922
US Classification:

424 94, 4241841, 4242751, 424539, 424810
Abstract:

The modulation or elimination of an allergic condition according to the invention can be achieved by injecting small amounts of allergen directly into a lymph node, which greatly reduces the potential for side effects.

Apparatus And Method For Delivery Of Therapeutic And Other Types Of Agents
view source
US Patent:

8267905, Sep 18, 2012
Filed:

May 1, 2006
Appl. No.:

11/414543
Inventors:

Thomas J. Lobl - Valencia CA, US
Stephen J. McCormack - Claremont CA, US
Anna Imola Nagy - Valencia CA, US
Jacob E. Pananen - Los Angeles CA, US
John V. Schloss - Valencia CA, US
Assignee:

NeuroSystec Corporation - Valencia CA
International Classification:

A61M 31/00
A61M 37/00
A61K 9/22
US Classification:

60428801, 6048901, 6048911, 6048921
Abstract:

Implantable drug delivery systems target delivery of small volumes of drugs to specific tissues. In some cases, a drug delivery system includes an implantable osmotic pump connected to a drug-containing housing, with that housing connected to a needle, cochlear implant or other type of component for ultimate delivery to the target tissue. In some implementations, a subcutaneous port receives a fluid from an external pump. The port is connected to a needle or other component for delivery of one or more drugs to the target tissue. Both solid and liquid drug formulations can be used. In embodiments using solid drugs, a separate drug vehicle (such as saline) can be used to dissolve a portion of the solid drug, with the drug-loaded vehicle then delivered to the target tissue.

Gacyclidine Formulations
view source
US Patent:

20060205789, Sep 14, 2006
Filed:

Mar 6, 2006
Appl. No.:

11/367720
Inventors:

Thomas Lobl - Valencia CA, US
John Schloss - Valencia CA, US
Stephen McCormack - Claremont CA, US
Anna Nagy - Valencia CA, US
Jacob Pananen - Los Angeles CA, US
Assignee:

NeuroSystec Corporation - Valencia CA
International Classification:

A61K 31/453
US Classification:

514326000
Abstract:

Improved formulations of gacyclidine for direct administration to the inner or middle ear.

Apparatus And Method For Delivering Therapeutic And/Or Other Agents To The Inner Ear And To Other Tissues
view source
US Patent:

20060264897, Nov 23, 2006
Filed:

Jan 24, 2006
Appl. No.:

11/337815
Inventors:

Thomas Lobl - Valencia CA, US
Stephen McCormack - Claremont CA, US
Thomas Lenarz - Hannover, DE
John Schloss - Valencia CA, US
Anna Nagy - Valencia CA, US
Jacob Pananen - Los Angeles CA, US
Assignee:

NeuroSystec Corporation - Valencia CA
International Classification:

A61M 31/00
A61M 5/00
A61N 1/00
A61M 37/00
US Classification:

604506000, 604117000, 604288010, 607137000
Abstract:

An apparatus may include a needle for sustained delivery of drugs and other agents to the inner ear or other tissues of a human or an animal. The needle can include an insertion stop, and can be placed through the round window membrane or through a surgically-prepared hole in a bone. The needle can be in fluid communication with a port and/or with a micro-infusion or osmotic pump. A cochlear implant electrode can be used instead of a needle.

Cochlear Implant With Localized Fluid Transport
view source
US Patent:

20110077579, Mar 31, 2011
Filed:

Mar 23, 2006
Appl. No.:

11/387206
Inventors:

William V. Harrison - Valencia CA, US
Thomas J. Lobl - Valencia CA, US
Stephen J. McCormack - Claremont CA, US
International Classification:

A61F 11/04
A61N 1/05
A61N 1/36
US Classification:

604 20, 607137
Abstract:

An apparatus for providing fluid communication with a cochlear lumen, the apparatus includes a delivery-tube configured for insertion into the cochlear lumen. Delivery-tube orifices on the delivery-tube provide fluid communication between a lumen defined by the delivery-tube and the cochlear lumen.

Gacyclidine Formulations
view source
US Patent:

20110136870, Jun 9, 2011
Filed:

Feb 4, 2011
Appl. No.:

13/021264
Inventors:

Thomas Jay Lobl - Valencia CA, US
John Vinton Schloss - Valencia CA, US
Stephen Joseph McCormack - Claremont CA, US
Anna Imola Nagy - Valencia CA, US
Jacob E. Pananen - Los Angeles CA, US
Assignee:

NEUROSYSTEC CORPORATION - Valencia CA
International Classification:

A61K 31/4535
A61P 27/16
US Classification:

514326
Abstract:

Improved formulations of gacyclidine for direct administration to the inner or middle ear.

Evaluation Of Changes In Breast Cells Using Nipple Aspirate Fluid
view source
US Patent:

63161893, Nov 13, 2001
Filed:

Oct 23, 1998
Appl. No.:

9/176928
Inventors:

Bassem R. Haddad - Rockville MD
Robert B. Dickson - Silver Spring MD
Stephen J. McCormack - Sag Harbor NY
Assignee:

Georgetown University School of Medicine - Washington DC
International Classification:

C12Q 168
C12P 1934
C12N 508
C12N 1512
US Classification:

435 6
Abstract:

This invention provides a method for studying chromosomal gains and losses in cells from nipple aspirate fluid comprising the steps of: (1) aspirating fluid from breasts; (2) placing the samples of fluid obtained in step 1 onto dishes containing conditioned medium composed of a mixture of (a) supernatant from immortalized mammary epithelial cells and (b) mammary epithelial growth medium; (3) incubating the product of step 2 in a humidified incubator; (4) replenishing the medium in the dishes prepared in step 2 at regular intervals to maintain cell growth; (5) isolating the cells from the cultures; (6) preparing DNA from these cells; (7) amplifying the DNA; (8) labeling an aliquot of the amplified DNA; and (9) evaluating the labeled DNA for evidence of chromosomal gains or losses.

Antigen-Binding Fusion Proteins With Modified Hsp70 Domains
view source
US Patent:

20200095332, Mar 26, 2020
Filed:

Aug 5, 2019
Appl. No.:

16/532200
Inventors:

- Boston MA, US
Mark C. Poznansky - Newton Center MA, US
Jeffrey A. Gelfand - Cambrdige MA, US
Huabiao Chen - Winchester MA, US
Stephen J. McCormack - Las Vegas NV, US
International Classification:

C07K 16/30
C07K 14/35
Abstract:

The invention relates to fusion proteins comprising an antigen binding domain fused with a modified heat shock 70 protein. The invention further relates to methods of using the fusion proteins to induce an immune response to antigens and to treat diseases associated With antigens.